Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Ángeles Castilla

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Endocrine-Related Cancer|April 15, 2015
Nuclear TAZ expression associates with the triple-negative phenotype in breast cancerJuan Díaz-Martín, María Ángeles López-García, Laura Romero-Pérez, et al.
Plos One|November 1, 2012
MicroRNA-200 family modulation in distinct breast cancer phenotypesMaría Ángeles Castilla, Juan Díaz-Martín, David Sarrió, et al.
Human Pathology|December 4, 2012
Oncogene alterations in endometrial carcinosarcomasMichele Biscuola, Koen Van de Vijver, María Ángeles Castilla, et al.
The Journal of Pathology|December 3, 2010
Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcomaMaría Ángeles Castilla, Gema Moreno-Bueno, Laura Romero-Pérez, et al.
Endocrine-Related Cancer|June 4, 2014
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancerMaría Ángeles Castilla, María Ángeles López-García, María Reina Atienza, et al.
Human Pathology|September 15, 2012
Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesisLaura Romero-Pérez, María Ángeles Castilla, María Ángeles López-García, et al.
Therapeutic Advances in Medical Oncology|December 30, 2024
Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expressionIsabel Miras, Ana Gil, Marta Benavent, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Endocrine-Related Cancer|April 15, 2015
Nuclear TAZ expression associates with the triple-negative phenotype in breast cancerJuan Díaz-Martín, María Ángeles López-García, Laura Romero-Pérez, et al.
Plos One|November 1, 2012
MicroRNA-200 family modulation in distinct breast cancer phenotypesMaría Ángeles Castilla, Juan Díaz-Martín, David Sarrió, et al.
Human Pathology|December 4, 2012
Oncogene alterations in endometrial carcinosarcomasMichele Biscuola, Koen Van de Vijver, María Ángeles Castilla, et al.
The Journal of Pathology|December 3, 2010
Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcomaMaría Ángeles Castilla, Gema Moreno-Bueno, Laura Romero-Pérez, et al.
Endocrine-Related Cancer|June 4, 2014
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancerMaría Ángeles Castilla, María Ángeles López-García, María Reina Atienza, et al.
Human Pathology|September 15, 2012
Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesisLaura Romero-Pérez, María Ángeles Castilla, María Ángeles López-García, et al.
Therapeutic Advances in Medical Oncology|December 30, 2024
Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expressionIsabel Miras, Ana Gil, Marta Benavent, et al.
Pageof 1